Suppr超能文献

ATP1A1基因的体细胞突变与醛固酮瘤

Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas.

作者信息

Gomez-Sanchez Celso E, Kuppusamy Maniselvan, Gomez-Sanchez Elise P

机构信息

Division of Endocrinology, G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS, USA; Department of Medicine-Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA.

Department of Medicine-Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA.

出版信息

Mol Cell Endocrinol. 2015 Jun 15;408:213-9. doi: 10.1016/j.mce.2014.12.004. Epub 2014 Dec 10.

Abstract

Primary aldosteronism is the most common form of secondary hypertension. It affects approximately 10% of patients with hypertension and causes greater cardiovascular morbidity and mortality compared to essential hypertension of similar severity and duration. The cause of primary aldosteronism in about half of these patients is an aldosterone-producing adenoma; over half of these adenomas have mutations in one of several ion channels and pumps, including the potassium channel KCNJ5, calcium channel Cav1.3, α1 subunit of the sodium potassium ATPase, and membrane calcium ATPase 3. This review concentrates on the molecular and physiological mechanisms by which mutations of the ATP1A1 gene increase aldosterone production.

摘要

原发性醛固酮增多症是继发性高血压最常见的形式。它影响约10%的高血压患者,与严重程度和病程相似的原发性高血压相比,会导致更高的心血管发病率和死亡率。在这些患者中,约一半原发性醛固酮增多症的病因是醛固酮分泌腺瘤;这些腺瘤中超过一半在几种离子通道和泵中的一种发生了突变,包括钾通道KCNJ5、钙通道Cav1.3、钠钾ATP酶的α1亚基和膜钙ATP酶3。本综述集中于ATP1A1基因突变增加醛固酮分泌的分子和生理机制方面。

相似文献

1
Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas.
Mol Cell Endocrinol. 2015 Jun 15;408:213-9. doi: 10.1016/j.mce.2014.12.004. Epub 2014 Dec 10.
2
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30.
3
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.
Nat Genet. 2013 Apr;45(4):440-4, 444e1-2. doi: 10.1038/ng.2550. Epub 2013 Feb 17.
4
Novel genes in primary aldosteronism.
Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):154-8. doi: 10.1097/MED.0000000000000060.
5
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Hypertension. 2014 Aug;64(2):354-61. doi: 10.1161/HYPERTENSIONAHA.114.03419. Epub 2014 May 27.
6
Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel Mutation.
Hypertension. 2017 Jul;70(1):129-136. doi: 10.1161/HYPERTENSIONAHA.117.09057. Epub 2017 Jun 5.
7
Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Endocr Relat Cancer. 2015 Oct;22(5):735-44. doi: 10.1530/ERC-15-0321.
8
Genetics of Primary Aldosteronism.
Hypertension. 2022 May;79(5):887-897. doi: 10.1161/HYPERTENSIONAHA.121.16498. Epub 2022 Feb 10.
9
RNA Sequencing Provides Novel Insights into the Transcriptome of Aldosterone Producing Adenomas.
Sci Rep. 2019 Apr 18;9(1):6269. doi: 10.1038/s41598-019-41525-2.
10
Somatic and inherited mutations in primary aldosteronism.
J Mol Endocrinol. 2017 Jul;59(1):R47-R63. doi: 10.1530/JME-17-0035. Epub 2017 Apr 11.

引用本文的文献

1
Diseases caused by mutations in the Na/K pump α1 gene .
Am J Physiol Cell Physiol. 2021 Aug 1;321(2):C394-C408. doi: 10.1152/ajpcell.00059.2021. Epub 2021 Jul 7.
2
On the effect of hyperaldosteronism-inducing mutations in Na/K pumps.
J Gen Physiol. 2017 Nov 6;149(11):1009-1028. doi: 10.1085/jgp.201711827. Epub 2017 Oct 13.
3
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions.
J Hum Hypertens. 2016 Jun;30(6):374-8. doi: 10.1038/jhh.2015.98. Epub 2015 Oct 8.

本文引用的文献

2
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Hypertension. 2014 Aug;64(2):354-61. doi: 10.1161/HYPERTENSIONAHA.114.03419. Epub 2014 May 27.
3
Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
J Clin Endocrinol Metab. 2014 Jul;99(7):E1341-51. doi: 10.1210/jc.2013-4255. Epub 2014 Apr 23.
4
Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
Endocrinology. 2014 Apr;155(4):1353-62. doi: 10.1210/en.2013-1944. Epub 2014 Feb 7.
5
Molecular mechanism of Na(+),K(+)-ATPase malfunction in mutations characteristic of adrenal hypertension.
Biochemistry. 2014 Feb 4;53(4):746-54. doi: 10.1021/bi401425g. Epub 2014 Jan 24.
7
Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
Endocrinology. 2014 Jan;155(1):47-55. doi: 10.1210/en.2013-1733. Epub 2013 Dec 20.
8
Crystal structure of a Na+-bound Na+,K+-ATPase preceding the E1P state.
Nature. 2013 Oct 10;502(7470):201-6. doi: 10.1038/nature12578. Epub 2013 Oct 2.
9
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30.
10
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.
Nat Genet. 2013 Sep;45(9):1055-60. doi: 10.1038/ng.2716. Epub 2013 Aug 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验